Loading clinical trials...

Famvir for Treatment of Hearing in Unilateral Meniere's Disease | Clinical Trials | Clareo Health

TERMINATEDPhase 3NCT01526408

Famvir for Treatment of Hearing in Unilateral Meniere's Disease

The specific aim of this study is to determine the efficacy of treatment with famciclovir in unilateral Meniere's Disease patients, specifically whether hearing can be improved. The investigators will...

Lead sponsor: House Research Institute•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 3

SPI-1005 for the Treatment of Meniere's Disease (Open Label)

NCT06859788 · Meniere's Disease, Ménière's Disease

SUSPENDEDNA

CAVA: Dizziness Trial

NCT04026516 · Meniere's Disease, Benign Paroxysmal Positional Vertigo, and more

TERMINATEDPhase 3

A 6-Month Extension Study of OTO-104 in Meniere's Disease

NCT02768662 · Meniere's Disease

TERMINATEDPhase 4

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease

NCT02530931 · Meniere's Disease

COMPLETEDNA

Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach

NCT02309099 · Unilateral Acoustic Neuroma, Meniere's Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 19, 2021Terms

Trial snapshot

StatusTERMINATED

PhasePHASE3

Enrollment11

Start dateDec 2011

Last updatedApr 19, 2021

Condition

Meniere's Disease

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions